Cancer Pain
Conditions
Keywords
mini program, self management, cancer pain
Brief summary
With the existing medical system and insufficient medical resources in China, we developed a mini program. a pain management mini app can be useful and appreciated by patients and health care professionals, making it a good choice for the management of cancer pain in our country . our study want to develop and test the mini program for pain management among Chinese cancer patients in or discharged from hospital treatment.
Detailed description
Healthcare interventions delivered via personal mobile device have been shown to be acceptable to users, who have identified benefits such as convenience, access to personalized information, greater awareness of own health. Integrating mini program into the cancer pain care may be an effective strategy to improve cancer pain patients self-management. To design, construct, and test the mini program in patients managing cancer pain, evaluate the total remission rate of pain and the improvement in medicine compliance to improve pain management for cancer pain patients, and assess patient acceptance of the mini program.
Interventions
OTHERmini program
To design, construct, and test the mini program in patients managing cancer pain
conventional pharmaceutical care
Sponsors
Fujian Cancer Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
The experiment involved two groups: a mini program trial group and a control group.
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients aged 18 years or older; * Be able to read Chinese and use a mobile phone; * Histologically or cytologically confirmed solid tumor; * Diagnosed chronic cancer pain * Could understand the study process and evaluation, agreed to participate in the trial, and signed the informed consent form.
Exclusion criteria
* Illiterate person; * Incompetence; * Inability to complete the pain assessment; * Participation in any other therapies or other study protocols that may have an impact on pain intensity, which were the main outcomes of this study;
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in pain score | Change from baseline at four weeks after discharge | Comparison of pain score of cancer pain patients with or without mini program. Pain score will be assessed by using numeric rating scale (NRS). An NRS allows a person to describe the intensity of his/her pain as a number usually ranging from 0 to 10, where 0 means no pain and 10 means pain as bad as it could be. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in medication adherence | Change from baseline at four weeks after discharge | The investigators will measure the change in medication adherence via Morisky Scale. Morisky Scale contains 4 questions, and the total score ranges from 0 to 4 with lower scores indicating higher adherence. |
| Incidence of adverse events | Up to four weeks after discharge | Adverse events will be assessed throughout the study according the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Event (CTCAE) Version 4.0. Number of subjects who experienced an adverse event in this study is presented. |
| Change in quality of life | Change from baseline at four weeks after discharge | Comparison of quality of life of cancer pain patients with or without mini program. Quality of life is assessed using EuroQol- 5 Dimension (EQ-5D). |
Contacts
Primary ContactQiuLing Zhao
Outcome results
None listed